Search
Descriptor English: Designer Drugs
Descriptor Spanish: Drogas de Diseño
Descriptor drogas de diseño
Entry term(s) droga de diseño
fármaco personalizado
Scope note: Drogas diseñadas y sintetizadas, a menudo para el uso ilegal en la calle, mediante modificación de la estructura de drogas existentes (por ejemplo anfetaminas). Son de especial interés la MPTP (éster inverso de la meperidina), MDA (3,4-metilenedioxianfetamina), y MDMA (3,4-metilenedioximetanfetamina). Muchas drogas actúan sobre el sistema aminérgico, aminas biogénicas fisiológicamente activas.
Descriptor Portuguese: Drogas Desenhadas
Descriptor French: Drogues fabriquées clandestinement
Entry term(s): Customized Drug
Customized Drugs
Designer Drug
Drug, Customized
Drug, Designer
Drugs, Customized
Drugs, Designer
Tree number(s): D26.909.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D015198
Scope note: Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
Annotation: coordinate with specific drug or chemical; do not confuse with DRUG DESIGN
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
Previous Indexing: Chemistry, Pharmaceutical (1984-1988)
Street Drugs (1985-1988)
Public MeSH Note: 1989
History Note: 1989
Related: Illicit Drugs MeSH
Substance-Related Disorders MeSH
DeCS ID: 23605
Unique ID: D015198
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1989/01/01
Date of Entry: 1988/04/23
Revision Date: 2020/05/27
Designer Drugs - Preferred
Concept UI M0023353
Scope note Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
Preferred term Designer Drugs
Entry term(s) Customized Drug
Customized Drugs
Designer Drug
Drug, Customized
Drug, Designer
Drugs, Customized
Drugs, Designer



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey